 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 February 1994 | Volume 120 Issue 3 | Pages 207-210
Objective: To study the influence of glucocorticoid replacement therapy on bone mineral density.
Design: Cross-sectional.
Setting: University hospital in the Netherlands.
Patients: 91 patients with Addison disease who had been receiving glucocorticoid replacement therapy for a mean of 10.6 years (range, 0.5 to 36.5 years).
Measurements: Bone mineral density of the lumbar spine and both femoral necks using a dual-energy x-ray absorptiometer and basal serum concentrations of adrenocorticotropin, gonadal hormones, and adrenal androgens.
Results: Decreased bone mineral density (< 2 standard deviations [SD] of the mean value of an age-matched reference population) was found in 10 of 31 men (32%; 95% CI, 17% to 51%) and in 4 of 60 women (7%; CI, 2% to 16%). No statistically significant differences were found between men and women with regard to age, duration of glucocorticoid substitution, or glucocorticoid dose, either in absolute quantities or when expressed per kilogram of body weight. However, in men with decreased bone mineral density, the daily hydrocortisone dose per kilogram of body weight (0.43 ±0.08 mg/kg; mean ±SD) was significantly (P = 0.032) higher than in men with normal bone mineral density (0.35 ±0.10 mg/kg). After correction for possible confounding variables, a significant linear correlation was found between hydrocortisone dose per kilogram of body weight and bone mineral density of the lumbar spine in the men (regression coefficient, –0.86;CI, –1.60 to –0.13;P = 0.029) but not in the women.
Conclusions: Long-term treatment with standard replacement doses of glucocorticoids may induce bone loss in men with Addison disease. Adjustment of glucocorticoid therapy to the lowest acceptable dose is mandatory in Addison disease, and regular measurement of bone mineral density may be helpful in identifying men at risk for the development of osteoporosis.
Author and Article Information
From the University Hospital, Utrecht, the Netherlands.
ARTICLE
Effect of Glucocorticoid Replacement Therapy on Bone Mineral Density in Patients with Addison Disease
Requests for Reprints: P.M.J. Zelissen, MD, Department of Endocrinology, University Hospital Utrecht, P.O. Box 85500, 3508 GA Utrecht, the Netherlands.
Acknowledgment: The authors thank The Dutch Addison Society (N.V.A.P.) for their cooperation and support of this study.
This article has been cited by other articles:
|
|
 |
|
  M. Sciannamblo, G. Russo, D. Cuccato, G. Chiumello, and S. Mora Reduced Bone Mineral Density and Increased Bone Metabolism Rate in Young Adult Patients with 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4453 - 4458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. King, A. B. Wisniewski, B. J. Bankowski, K. A. Carson, H. A. Zacur, and C. J. Migeon Long-Term Corticosteroid Replacement and Bone Mineral Density in Adult Women with Classical Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 865 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Weinstein 11{beta}-HSD: Guardian or Gate Crasher? IBMS BoneKEy, September 1, 2005; 2(9): 6 - 13. [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Adler and M. C. Hochberg Suggested Guidelines for Evaluation and Treatment of Glucocorticoid-Induced Osteoporosis for the Department of Veterans Affairs Arch Intern Med, November 24, 2003; 163(21): 2619 - 2624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. M. L. Stikkelbroeck, W. J. G. Oyen, G.-J. van der Wilt, A. R. M. M. Hermus, and B. J. Otten Normal Bone Mineral Density and Lean Body Mass, but Increased Fat Mass, in Young Adult Patients with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1036 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Lovas, G. Gebre-Medhin, T. S. Trovik, K. J. Fougner, S. Uhlving, B. G. Nedrebo, O. L. Myking, O. Kampe, and E. S. Husebye Replacement of Dehydroepiandrosterone in Adrenal Failure: No Benefit for Subjective Health Status and Sexuality in a 9-Month, Randomized, Parallel Group Clinical Trial J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1112 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. G. Kemink, J. T. M. Frijns, A. R. M. M. Hermus, G. F. F. M. Pieters, A. G. H. Smals, and W. D. Van Marken Lichtenbelt Body Composition Determined by Six Different Methods in Women Bilaterally Adrenalectomized for Treatment of Cushing's Disease J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3991 - 3999. [Abstract] [Full Text]
|
|
|
|
|
|
E. Dennison, P. Hindmarsh, C. Fall, S. Kellingray, D. Barker, D. Phillips, and C. Cooper Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3058 - 3063. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. S. Krasner Glucocorticoid-Induced Adrenal Insufficiency JAMA, August 18, 1999; 282(7): 671 - 676. [Full Text] [PDF]
|
|
|
|
|
|
A. Colao, C. Di Somma, R. Pivonello, S. Loche, G. Aimaretti, G. Cerbone, A. Faggiano, G. Corneli, E. Ghigo, and G. Lombardi Bone Loss Is Correlated to the Severity of Growth Hormone Deficiency in Adult Patients with Hypopituitarism J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1919 - 1924. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Whooley, K. E. Kip, J. A. Cauley, K. E. Ensrud, M. C. Nevitt, W. S. Browner, and for the Study of Osteoporotic Fractures Research G Depression, Falls, and Risk of Fracture in Older Women Arch Intern Med, March 8, 1999; 159(5): 484 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ferretti, L. Persani, M.-L. Jaffrain-Rea, S. Giambona, G. Tamburrano, and P. Beck-Peccoz Evaluation of the Adequacy of Levothyroxine Replacement Therapy in Patients with Central Hypothyroidism J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 924 - 929. [Abstract] [Full Text]
|
|
|
|
|
|
G. P. B. Kraan, R. P. F. Dullaart, J. J. Pratt, B. G. Wolthers, N. M. Drayer, and R. de Bruin The Daily Cortisol Production Reinvestigated in Healthy Men. The Serum and Urinary Cortisol Production Rates Are Not Significantly Different J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1247 - 1252. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kleerekoper, R. Schiebinger, and J. P. Gutai Steroid Therapy for Adrenal Disorders--Getting the Dose Right J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3923 - 3925. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gussinye, A. Carrascosa, N. Potau, M. Enrubia, E. Vicens-Calvet, L. Ibanez, and D. Yeste Bone Mineral Density in Prepubertal and in Adolescent and Young Adult Patients With the Salt-wasting Form of Congenital Adrenal Hyperplasia Pediatrics, October 1, 1997; 100(4): 671 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Michelson, C. Stratakis, L. Hill, J. Reynolds, E. Galliven, G. Chrousos, and P. Gold Bone Mineral Density in Women with Depression N. Engl. J. Med., October 17, 1996; 335(16): 1176 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Oelkers Adrenal Insufficiency N. Engl. J. Med., October 17, 1996; 335(16): 1206 - 1212. [Full Text] [PDF]
|
|
Article
